Meeting Posters

Prospectively specified adaptive Bayesian borrowing considerations methodologies and implementations (Abstract)

Mukhopadhyay
2024 Autumn Conference

Central monitoring and data quality assurance identifying and correcting errors in fluency tests in CNS trials (Abstract)

Miller
2024 Autumn Conference

Quantifying exposure: Novel methods to investigate exposure treatments for trauma-related nightmares (Abstract)

Medvescek
2024 Autumn Conference

EEG-based machine learning biomarker to predict treatment response from SSRI and TMS treatment of MDD and TRD patients (Abstract)

Li
2024 Autumn Conference

Raters associated with erratic ratings differ in their scoring technique (Abstract)

Kott
2024 Autumn Conference

Impact of low-recruiting sites on data quality in early Alzheimer’s disease clinical trials (Abstract)

Kott
2024 Autumn Conference

Standardized EEG/ERP battery for measuring drug effects in CNS trials using end-to-end automated analytic pipeline (Abstract)

Korolev
2024 Autumn Conference

Equating CDRS-R and MADRS scale scores in adolescents with major depressive disorder with acute suicidal ideation or behavior (Abstract)

Kosik-Gonzalez
2024 Autumn Conference

The utility of the NIDA Phenotyping Assessment Battery in a combined enrichment strategy for determining eligibility in addiction clinical trials (Abstract)

Keyser-Marcus
2024 Autumn Conference

Integrating synchronous AI-based fidelity adherence monitoring of facilitators in psychedelic clinical trials (Abstract)

Kelman
2024 Autumn Conference

Audio and video digital measurements observed in naturalistic settings predict PANSS Marder factor scores in schizophrenia (Abstract)

Kark
2024 Autumn Conference

Equipercentile linking masks data quality concerns in depression clinical trials (Abstract)

Karazsia
2024 Autumn Conference

Functional unblinding evaluation of central raters in a large psychedelic clinical trial (Abstract)

Karas
2024 Autumn Conference

Longitudinal convergence of dispersed clinical ratings and ecological momentary assessment burst assessments of negative symptoms in schizophrenia (Abstract)

Horan
2024 Autumn Conference

A clinical trial inclusion criteria to enrich for patients presenting with canonical symptom structure in bipolar depression (Abstract)

Hopkins
2024 Autumn Conference

Examining negative symptoms and everyday functioning as a correlated time series: Causal analysis of treatment effects in a 12-month open-label study (Abstract)

Harvey
2024 Autumn Conference

Insights from the CATIE schizophrenia trial: AI/ML-driven analysis to identify key variables influencing treatment outcomes (Abstract)

Geraci
2024 Autumn Conference

Development of the Treatment Attitude Profile (TAP) scale: AI/ML-driven insights for clinical trial enrichment to minimize placebo response (Abstract)

Geraci
2024 Autumn Conference

Correcting speaker labeling errors in automated transcripts of clinical conversations (Abstract)

Efstathiadis
2024 Autumn Conference

Comparing effectiveness of manufacturer-recommended therapeutic ADT dose as detailed in the Antidepressant Treatment Response Questionnaire (ATRQ) (Abstract)

Desjardins
2024 Autumn Conference